Logo image of ARHS

ARHAUS INC (ARHS) Stock Fundamental Analysis

NASDAQ:ARHS - Nasdaq - US04035M1027 - Common Stock - Currency: USD

9.39  -0.16 (-1.68%)

After market: 9.45 +0.06 (+0.64%)

Fundamental Rating

6

Taking everything into account, ARHS scores 6 out of 10 in our fundamental rating. ARHS was compared to 121 industry peers in the Specialty Retail industry. ARHS scores excellent on profitability, but there are some minor concerns on its financial health. ARHS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ARHS had positive earnings in the past year.
ARHS had a positive operating cash flow in the past year.
Each year in the past 5 years ARHS has been profitable.
ARHS had a positive operating cash flow in each of the past 5 years.
ARHS Yearly Net Income VS EBIT VS OCF VS FCFARHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

With a decent Return On Assets value of 4.61%, ARHS is doing good in the industry, outperforming 66.94% of the companies in the same industry.
With a decent Return On Equity value of 16.72%, ARHS is doing good in the industry, outperforming 74.38% of the companies in the same industry.
ARHS has a Return On Invested Capital of 6.60%. This is in the better half of the industry: ARHS outperforms 63.64% of its industry peers.
ARHS had an Average Return On Invested Capital over the past 3 years of 16.29%. This is above the industry average of 13.07%.
The 3 year average ROIC (16.29%) for ARHS is well above the current ROIC(6.60%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.61%
ROE 16.72%
ROIC 6.6%
ROA(3y)10.56%
ROA(5y)7.82%
ROE(3y)40.63%
ROE(5y)N/A
ROIC(3y)16.29%
ROIC(5y)17.01%
ARHS Yearly ROA, ROE, ROICARHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

ARHS has a better Profit Margin (4.53%) than 75.21% of its industry peers.
ARHS's Profit Margin has improved in the last couple of years.
ARHS has a better Operating Margin (5.67%) than 72.73% of its industry peers.
ARHS's Operating Margin has improved in the last couple of years.
ARHS has a Gross Margin (38.98%) which is in line with its industry peers.
ARHS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.67%
PM (TTM) 4.53%
GM 38.98%
OM growth 3Y16.64%
OM growth 5Y2.23%
PM growth 3Y26.76%
PM growth 5Y18.12%
GM growth 3Y-1.61%
GM growth 5Y2.07%
ARHS Yearly Profit, Operating, Gross MarginsARHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ARHS is creating some value.
ARHS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ARHS has been increased compared to 5 years ago.
The debt/assets ratio for ARHS has been reduced compared to a year ago.
ARHS Yearly Shares OutstandingARHS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M
ARHS Yearly Total Debt VS Total AssetsARHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.35 indicates that ARHS is not a great score, but indicates only limited risk for bankruptcy at the moment.
ARHS's Altman-Z score of 2.35 is in line compared to the rest of the industry. ARHS outperforms 52.89% of its industry peers.
ARHS has a debt to FCF ratio of 1.11. This is a very positive value and a sign of high solvency as it would only need 1.11 years to pay back of all of its debts.
ARHS's Debt to FCF ratio of 1.11 is amongst the best of the industry. ARHS outperforms 80.99% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that ARHS is not too dependend on debt financing.
ARHS's Debt to Equity ratio of 0.15 is fine compared to the rest of the industry. ARHS outperforms 68.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.11
Altman-Z 2.35
ROIC/WACC0.7
WACC9.49%
ARHS Yearly LT Debt VS Equity VS FCFARHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.26 indicates that ARHS should not have too much problems paying its short term obligations.
ARHS's Current ratio of 1.26 is in line compared to the rest of the industry. ARHS outperforms 45.45% of its industry peers.
A Quick Ratio of 0.57 indicates that ARHS may have some problems paying its short term obligations.
ARHS's Quick ratio of 0.57 is in line compared to the rest of the industry. ARHS outperforms 57.85% of its industry peers.
The current and quick ratio evaluation for ARHS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.57
ARHS Yearly Current Assets VS Current LiabilitesARHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The earnings per share for ARHS have decreased strongly by -46.05% in the last year.
The Earnings Per Share has been growing by 43.52% on average over the past years. This is a very strong growth
ARHS shows a small growth in Revenue. In the last year, the Revenue has grown by 0.71%.
The Revenue has been growing by 20.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-46.05%
EPS 3Y48.09%
EPS 5Y43.52%
EPS Q2Q%-63.64%
Revenue 1Y (TTM)0.71%
Revenue growth 3Y16.84%
Revenue growth 5Y20.78%
Sales Q2Q%5.49%

3.2 Future

Based on estimates for the next years, ARHS will show a small growth in Earnings Per Share. The EPS will grow by 6.67% on average per year.
ARHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.21% yearly.
EPS Next Y-12.94%
EPS Next 2Y1.27%
EPS Next 3Y6.39%
EPS Next 5Y6.67%
Revenue Next Year5.1%
Revenue Next 2Y6.36%
Revenue Next 3Y6.97%
Revenue Next 5Y7.21%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ARHS Yearly Revenue VS EstimatesARHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
ARHS Yearly EPS VS EstimatesARHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.90, ARHS is valued on the expensive side.
66.12% of the companies in the same industry are more expensive than ARHS, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.45. ARHS is around the same levels.
The Price/Forward Earnings ratio is 19.07, which indicates a rather expensive current valuation of ARHS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ARHS is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 21.90. ARHS is around the same levels.
Industry RankSector Rank
PE 22.9
Fwd PE 19.07
ARHS Price Earnings VS Forward Price EarningsARHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ARHS indicates a somewhat cheap valuation: ARHS is cheaper than 70.25% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ARHS is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 27.72
EV/EBITDA 7.59
ARHS Per share dataARHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

ARHS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.53
EPS Next 2Y1.27%
EPS Next 3Y6.39%

0

5. Dividend

5.1 Amount

No dividends for ARHS!.
Industry RankSector Rank
Dividend Yield N/A

ARHAUS INC

NASDAQ:ARHS (7/3/2025, 7:02:38 PM)

After market: 9.45 +0.06 (+0.64%)

9.39

-0.16 (-1.68%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners112.33%
Inst Owner Change2.12%
Ins Owners5.31%
Ins Owner Change7.77%
Market Cap1.32B
Analysts75
Price Target10.07 (7.24%)
Short Float %10.41%
Short Ratio3.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.5
Dividend Growth(5Y)N/A
DP120.85%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-12.05%
Min EPS beat(2)-36.28%
Max EPS beat(2)12.17%
EPS beat(4)2
Avg EPS beat(4)-1.88%
Min EPS beat(4)-36.28%
Max EPS beat(4)33.22%
EPS beat(8)6
Avg EPS beat(8)71.61%
EPS beat(12)10
Avg EPS beat(12)73.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.07%
Min Revenue beat(2)-3.15%
Max Revenue beat(2)-3%
Revenue beat(4)0
Avg Revenue beat(4)-3.62%
Min Revenue beat(4)-4.97%
Max Revenue beat(4)-3%
Revenue beat(8)3
Avg Revenue beat(8)-1.24%
Revenue beat(12)6
Avg Revenue beat(12)1.03%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.97%
PT rev (3m)-17.97%
EPS NQ rev (1m)0.63%
EPS NQ rev (3m)-4.35%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-13.68%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.86%
Valuation
Industry RankSector Rank
PE 22.9
Fwd PE 19.07
P/S 1.03
P/FCF 27.72
P/OCF 8.44
P/B 3.79
P/tB 3.92
EV/EBITDA 7.59
EPS(TTM)0.41
EY4.37%
EPS(NY)0.49
Fwd EY5.24%
FCF(TTM)0.34
FCFY3.61%
OCF(TTM)1.11
OCFY11.85%
SpS9.13
BVpS2.48
TBVpS2.4
PEG (NY)N/A
PEG (5Y)0.53
Profitability
Industry RankSector Rank
ROA 4.61%
ROE 16.72%
ROCE 8.82%
ROIC 6.6%
ROICexc 8.9%
ROICexgc 9.07%
OM 5.67%
PM (TTM) 4.53%
GM 38.98%
FCFM 3.71%
ROA(3y)10.56%
ROA(5y)7.82%
ROE(3y)40.63%
ROE(5y)N/A
ROIC(3y)16.29%
ROIC(5y)17.01%
ROICexc(3y)22.28%
ROICexc(5y)30.4%
ROICexgc(3y)22.81%
ROICexgc(5y)34.8%
ROCE(3y)21.77%
ROCE(5y)22.73%
ROICexcg growth 3Y-40.08%
ROICexcg growth 5Y-10.67%
ROICexc growth 3Y-36.41%
ROICexc growth 5Y-9.4%
OM growth 3Y16.64%
OM growth 5Y2.23%
PM growth 3Y26.76%
PM growth 5Y18.12%
GM growth 3Y-1.61%
GM growth 5Y2.07%
F-Score5
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.11
Debt/EBITDA 0.34
Cap/Depr 136.17%
Cap/Sales 8.47%
Interest Coverage 14.34
Cash Conversion 102.44%
Profit Quality 81.84%
Current Ratio 1.26
Quick Ratio 0.57
Altman-Z 2.35
F-Score5
WACC9.49%
ROIC/WACC0.7
Cap/Depr(3y)167.27%
Cap/Depr(5y)155.74%
Cap/Sales(3y)6.66%
Cap/Sales(5y)5.71%
Profit Quality(3y)44.67%
Profit Quality(5y)347.09%
High Growth Momentum
Growth
EPS 1Y (TTM)-46.05%
EPS 3Y48.09%
EPS 5Y43.52%
EPS Q2Q%-63.64%
EPS Next Y-12.94%
EPS Next 2Y1.27%
EPS Next 3Y6.39%
EPS Next 5Y6.67%
Revenue 1Y (TTM)0.71%
Revenue growth 3Y16.84%
Revenue growth 5Y20.78%
Sales Q2Q%5.49%
Revenue Next Year5.1%
Revenue Next 2Y6.36%
Revenue Next 3Y6.97%
Revenue Next 5Y7.21%
EBIT growth 1Y-46.83%
EBIT growth 3Y36.28%
EBIT growth 5Y23.47%
EBIT Next Year61.4%
EBIT Next 3Y28.16%
EBIT Next 5Y21.16%
FCF growth 1Y1293.43%
FCF growth 3Y-26.06%
FCF growth 5Y27.06%
OCF growth 1Y233.61%
OCF growth 3Y0.21%
OCF growth 5Y46.37%